125 related articles for article (PubMed ID: 26645191)
1. Progress in the treatment of juvenile dermatomyositis.
Miossec P
Lancet; 2016 Feb; 387(10019):627-628. PubMed ID: 26645191
[No Abstract] [Full Text] [Related]
2. The PRINTO juvenile dermatomyositis trial.
Dale A; Milosevic I; Goldacre B;
Lancet; 2016 Jun; 387(10038):2600-2601. PubMed ID: 27353816
[No Abstract] [Full Text] [Related]
3. The PRINTO juvenile dermatomyositis trial - Authors' reply.
Ruperto N; Pistorio A; Ravelli A; Angioloni S; Martini A;
Lancet; 2016 Jun; 387(10038):2601. PubMed ID: 27353819
[No Abstract] [Full Text] [Related]
4. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial.
Ruperto N; Pistorio A; Oliveira S; Zulian F; Cuttica R; Ravelli A; Fischbach M; Magnusson B; Sterba G; Avcin T; Brochard K; Corona F; Dressler F; Gerloni V; Apaz MT; Bracaglia C; Cespedes-Cruz A; Cimaz R; Couillault G; Joos R; Quartier P; Russo R; Tardieu M; Wulffraat N; Bica B; Dolezalova P; Ferriani V; Flato B; Bernard-Medina AG; Herlin T; Trachana M; Meini A; Allain-Launay E; Pilkington C; Vargova V; Wouters C; Angioloni S; Martini A;
Lancet; 2016 Feb; 387(10019):671-678. PubMed ID: 26645190
[TBL] [Abstract][Full Text] [Related]
5. The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients.
Giancane G; Lavarello C; Pistorio A; Oliveira SK; Zulian F; Cuttica R; Fischbach M; Magnusson B; Pastore S; Marini R; Martino S; Pagnier A; Soler C; Staņēvicha V; Ten Cate R; Uziel Y; Vojinovic J; Fueri E; Ravelli A; Martini A; Ruperto N;
Pediatr Rheumatol Online J; 2019 May; 17(1):24. PubMed ID: 31118099
[TBL] [Abstract][Full Text] [Related]
6. Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis.
Kasteler JS; Callen JP
J Am Acad Dermatol; 1997 Jan; 36(1):67-71. PubMed ID: 8996263
[TBL] [Abstract][Full Text] [Related]
7. Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis.
Reiff A; Rawlings DJ; Shaham B; Franke E; Richardson L; Szer IS; Bernstein BH
J Rheumatol; 1997 Dec; 24(12):2436-43. PubMed ID: 9415655
[TBL] [Abstract][Full Text] [Related]
8. Intramatricial injections for nail psoriasis: An open-label comparative study of triamcinolone, methotrexate, and cyclosporine.
Ravindran S; Criton S
Indian J Dermatol Venereol Leprol; 2019; 85(1):81-82. PubMed ID: 30457124
[No Abstract] [Full Text] [Related]
9. Author's reply.
Mahajan BB
Indian J Dermatol Venereol Leprol; 2019; 85(1):82-83. PubMed ID: 30504532
[No Abstract] [Full Text] [Related]
10. [Autoimmune myelofibrosis with dermatomyositis].
Sahali S; Ghosn J; Lazure T; Goujard C; Delfraissy JF; Lambotte O
Rev Med Interne; 2009 Jan; 30(1):71-3. PubMed ID: 18508162
[TBL] [Abstract][Full Text] [Related]
11. [Panniculitis in patient undergoing treatment for dermatomyositis with methotrexate].
Feki NB; Khanfir MS; Ghorbel IB; Said F; Houman MH
Pan Afr Med J; 2016; 23():149. PubMed ID: 27279974
[TBL] [Abstract][Full Text] [Related]
12. Panniculitis associated with amyopathic dermatomyositis.
Azevedo PO; Castellen NR; Salai AF; Barbosa FS; Alves CAXM; Pinto CAL
An Bras Dermatol; 2018; 93(1):119-121. PubMed ID: 29641712
[TBL] [Abstract][Full Text] [Related]
13. Amyopathic dermatomyositis--an uncommon presentation of dermatomyositis.
Arnson Y; Dovrish Z; Hadari R; Amital H
Isr Med Assoc J; 2007 Jun; 9(6):492-3. PubMed ID: 17642406
[No Abstract] [Full Text] [Related]
14. Leflunomide as adjuvant treatment of dermatomyositis.
Boswell JS; Costner MI
J Am Acad Dermatol; 2008 Mar; 58(3):403-6. PubMed ID: 18194823
[TBL] [Abstract][Full Text] [Related]
15. The value of methotrexate in dermatomyositis.
Zieglschmid-Adams ME; Pandya A; Cohen SB; Sontheimer RD
J Am Acad Dermatol; 1998 Jan; 38(1):130-2. PubMed ID: 9448226
[No Abstract] [Full Text] [Related]
16. Koebner Phenomenon in Dermatomyositis after Subcutaneous Methotrexate Injections.
Couture P; Bachmeyer C; Monfort JB
J Rheumatol; 2019 Oct; 46(10):1350. PubMed ID: 31575735
[No Abstract] [Full Text] [Related]
17. Methotrexate Use and Risk of Interstitial Lung Disease in Dermatomyositis.
Shah JT; Richardson WM; Mittal L; Castillo R; Mazori DR; Caplan AS; Femia AN
JAMA Dermatol; 2024 Jun; 160(6):676-678. PubMed ID: 38691354
[TBL] [Abstract][Full Text] [Related]
18. Low-dose methotrexate as an adjunctive therapy with surgery for ectropion complicating dermatomyositis.
Abernethy ML; Arterberry JF; Callen JP
Dermatology; 1996; 192(2):153-5. PubMed ID: 8829501
[TBL] [Abstract][Full Text] [Related]
19. [What is your diagnosis? Pyoderma gangrenosum].
Wieler B; Vorburger D; Lindenmann N
Praxis (Bern 1994); 2009 Dec; 98(25):1497-8. PubMed ID: 20013685
[No Abstract] [Full Text] [Related]
20. Amyopathic dermatomyositis with plantar keratoderma responding to methotrexate therapy.
Morrell TJ; Mortensen WS; Langley S
Cutis; 2017 Aug; 100(2):E20-E24. PubMed ID: 28961302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
